(11) Patent Number | 034171 |
Date of Registration in the Register of Eurasian Patents | 2020.01.13 |
(21) Application Number | 201790137 |
(22) Filling Date | 2013.10.01 |
(51) IPC |
C07D 213/64 (2006.01)
C07D 401/04 (2006.01)
C07D 401/12 (2006.01)
C07D 401/14 (2006.01)
C07D 409/12 (2006.01)
A61K 31/4412 (2006.01)
A61K 31/4427 (2006.01)
A61K 31/444 (2006.01)
A61P 11/00 (2006.01) |
(43)(13) Application Publication Date(s), Kind Code(s) | A1 2017.11.30 Issue No 11  title, specification
|
(45)(13) Patent Publication Date(s), Kind Code(s) | B1 2020.01.14 Issue No 01 title, specification
|
(31) Number(s) assigned to Priority Application(s) | 61/709,075
61/777,499
61/872,157
|
(32) Date(s) of filing of Priority Application(s) | 2012.10.02
2013.03.12
2013.08.30
|
(33) Priority Application Office | US
US
US
|
(62) Number and date of filing of initial application, from which the present application has been divided | 201590477; 2013.10.01 |
(71) Applicant(s) | ИНТЕРМЬЮН, ИНК. (US) |
(72) Inventor(s) | Бакмэн Брэд Оуэн, Николас Джон Бимонд, Рамфал Джонни И., Емаян Кумарасвами, Сейверт Скотт Д. (US) |
(73) Patent Owner(s) | ИНТЕРМЬЮН, ИНК. (US) |
(54) Title | ПРОТИВОФИБРОЗНЫЕ ПИРИДИНОНЫ |
